AKAM · Akamai Technologies Inc · Insider Trading

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.05 to 126.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Held by The MMMM Family Living Trust, of which the Reporting Person is a trustee.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2026.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

On September 12, 2023, the Reporting Person was granted 3,845 RSUs. Such RSUs vest over three years as follows: 1/3 on the first anniversary of the date of grant with the remaining 2/3 vesting in equal installments of 8-1/3% each quarter thereafter.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2026.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

On September 12, 2023, the Reporting Person was granted 3,845 RSUs. Such RSUs vest over three years as follows: 1/3 on the first anniversary of the date of grant with the remaining 2/3 vesting in equal installments of 8-1/3% each quarter thereafter.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

On May 20, 2020, the Reporting Person was granted 2,336 deferred stock units, which vested one year following the grant date; however, the Reporting Person elected to defer distribution until a later date.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

On July 12, 2026, the Reporting Person was granted 3,028 deferred stock units, which vested in full and were distributed on May 14, 2026.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

On July 12, 2026, the Reporting Person was granted 3,028 deferred stock units, which vested in full and were distributed on May 14, 2026.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

On May 14, 2025, the Reporting Person was granted 3,547 deferred stock units, which vested in full and were distributed one year following the grant date.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Deferred stock units vest one year following the grant date; however, the Reporting Person elected to defer distribution until the earlier to occur of (i) May 13, 2028, (ii) a change in control (as defined under Code Section 409A), (iii) separation from service, or (iv) death.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Deferred stock units vest one year following the grant date; however, the Reporting Person elected to defer distribution until the earlier to occur of (i) May 13, 2028, (ii) a change in control (as defined under Code Section 409A), (iii) separation from service, or (iv) death.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Deferred stock units vest one year following the grant date; however, the Reporting Person elected to defer distribution until the earlier to occur of (i) May 13, 2036, (ii) a change in control (as defined under Code Section 409A), (iii) separation from service, or (iv) death.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Deferred stock units vest one year following the grant date.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Deferred stock units vest one year following the grant date; however, the Reporting Person elected to defer distribution until the earlier to occur of (i) May 13, 2030, (ii) a change in control (as defined under Code Section 409A), or (iii) death.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Deferred stock units vest one year following the grant date.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Deferred stock units vest one year following the grant date.

Each deferred stock unit represents the right to receive one share of Akamai common stock upon vesting.

Deferred stock units vest one year following the grant date; however, the Reporting Person elected to defer distribution until the earlier to occur of (i) May 13, 2036, (ii) a change in control (as defined under Code Section 409A), (iii) separation from service, or (iv) death.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2025.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.39 to $106.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.2463 to $106.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Total shares beneficially owned includes 5,982 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan.

Held by the Aaron Ahola Revocable Trust for which the Reporting Person serves as trustee.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.41 to $107.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

On September 12, 2023, the Reporting Person was granted 3,845 RSUs. Such RSUs vest over three years as follows: 1/3 on the first anniversary of the date of grant with the remaining 2/3 vesting in equal installments of 8-1/3% each quarter thereafter.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.39 to $107.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Total shares beneficially owned includes 14,222 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.65 to $105.275, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.645 to $104.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Sale was made pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 4, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.485 to $101.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Total shares beneficially owned includes 29,800 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan.

Sale was made pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 4, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.52 to $101.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Total shares beneficially owned includes 29,800 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan.

Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2025.

Held by The MMMM Family Living Trust, of which the Reporting Person is a trustee.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

On March 6, 2023, the Reporting Person was granted 70,056 RSUs. Such RSUs vest over three years in equal installments on the first, second and third anniversaries of the grant date.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

On March 6, 2023, the Reporting Person was granted 19,348 RSUs. Such RSUs vest over three years in equal installments on the first, second and third anniversaries of the grant date.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

On March 6, 2023, the Reporting Person was granted 16,946 RSUs. Such RSUs vest over three years in equal installments on the first, second and third anniversaries of the grant date.

Total shares beneficially owned includes 29,800 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.

Each restricted stock unit ("RSU") represents the right to receive one share of Akamai common stock upon vesting.